Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 7/20 | 0.53 |
| ▸ | OPRL1 | P41146 | 4/20 | 0.53 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.41 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.41 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.41 |
| ▸ | TACR1 | P25103 | 4/20 | 0.40 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | F10 | P00742 | 1/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL374107 | 0.82 | OPRM1 (0.46) | OPRM1OPRL1SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL7305720 | 0.82 | ALDH1A1 (0.48) | OPRM1OPRL1KCNA3LMNASMN1; SMN2 | |
| SCHEMBL4630111 | 0.81 | SLC6A2 (0.45) | OPRM1OPRL1SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL7305853 | 0.81 | OPRM1 (0.45) | OPRM1OPRL1SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL7304290 | 0.80 | NPFFR1 (0.53) | OPRM1OPRL1KCNA3ALDH1A1 | |
| SCHEMBL4630753 | 0.80 | OPRM1 (0.56) | OPRM1OPRL1SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL8064379 | 0.77 | OPRM1 (0.47) | OPRM1OPRL1SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL8041537 | 0.76 | SLC6A4 (0.69) | OPRM1OPRL1SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL4630733 | 0.75 | OPRM1 (0.51) | OPRM1OPRL1SLC6A4TACR1 | |
| Hydrochloric Acid SCHEMBL7749155 | 0.74 | OPRM1 (0.50) | OPRM1OPRL1SLC6A4TACR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6294537-B1 | NEUROKININS USED FOR TREATMENT OF DISEASES | SANOFI-SYNTHELABO (FR) | 2001-09-25 | — | — | US | disclosed |
| US-6124316-A | ACTIVE DRUG TREATING PSYCHIATRIC DISEASES, DISEASES OF PSYCHOSOMATIC ORIGIN, OF HYPERTENSION AND, NERVOUS SYSTEM DISORDERS | SANOFI (FR) | 2000-09-26 | — | — | US | disclosed |
| US-5942523-A | NOVEL PIPERIDINE DERIVATIVES WHOSE SPECIFIC STRUCTURE INCLUDES AT POSITION 1 AN ALKYL CHAIN HAVING A 3,4-DICHLOROPHENYL GROUP ATTACHED; HIGH SELECTIVITY TO THE NK3 RECEPTOR; UNIT DOSAGE FORM; TREATING PSYCHIATRIC DISEASES | SANOFI (FR) | 1999-08-24 | — | — | US | disclosed |
| US-5741910-A | PIPERIDINE DERIVATIVE INTERMEDIATES | SANOFI (FR) | 1998-04-21 | — | — | US | disclosed |
| EP-0673928-A1 | Novel N-(3,4-dichlorophenyl-propyl)-piperidine derivatives as selective human NK3-receptor antagonists | SANOFI (FR) | 1995-09-27 | — | — | EP | disclosed |